Jagforce 100 Capsule contains Itraconazole 100 mg, a broad-spectrum antifungal agent used primarily for the treatment of various fungal infections. Itraconazole belongs to the triazole class of antifungals and works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This medication is indicated for the treatment of systemic and superficial mycoses including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and candidiasis. Jagforce 100 Capsule is administered orally and is well-absorbed, with bioavailability enhanced when taken with food. It is metabolized extensively in the liver via the cytochrome P450 system, necessitating caution in patients with hepatic impairment and potential drug interactions. Common adverse effects include gastrointestinal disturbances such as nausea, vomiting, and abdominal pain, as well as headache and dizziness. Liver function tests should be monitored periodically during prolonged therapy. Jagforce 100 Capsule should be used under medical supervision, with dosage adjustments based on the severity and type of infection. It is contraindicated in patients with known hypersensitivity to itraconazole and should be avoided in pregnancy unless clearly necessary.